Title : Nicotine pretreatment diminished physostigmine-induced tremor in rats - da Fonseca Ade_2005_Pharmacol.Biochem.Behav_81_551 |
Author(s) : da Fonseca Ade S , Santos R |
Ref : Pharmacol Biochem Behav , 81 :551 , 2005 |
Abstract :
The aim of this work was evaluate the effects of acute and chronic nicotine pretreatment in the physostigmine-induced tremor in rats. Wistar male rats (3-4 months) were pretreated acutely with different nicotine doses (0, 0.1, 0.5 or 1.0 mg/kg) 10 min before physostigmine (0 and 0.5 mg/kg) treatment and then the tremor was registered by computerized system for 10 min. In another group, rats were pretreated acutely with 0.1 mg/kg of nicotine, recovered at different times (30 or 70 min), and were registered for physostigmine-induced tremor. Nicotine was also used chronically with equal doses for 8 days and recovered at 2, 7 or 21 days before registration of physostigmine-induced tremor. Tremor spectral analysis was performed for amplitude and frequency quantification. Our data show that the acute and chronic nicotine pretreatments alter physostigmine spectrum profile. Nicotine decreased physostigmine-induced tremor amplitude (p<0.05), without changing its tremor frequency. In acutely pretreated rats, recovery experiments showed return of physostigmine-induced tremor for control levels after 70 min, but after 8 days of chronic nicotine pretreatment recovery was delayed 3 weeks. The data analysis shows that acute or chronic nicotine administration can alleviate the physostigmine-induced tremor. Chronic nicotine pretreatment has a long tremor alleviation effect of physostigmine-induced tremor. Possible mechanisms involving the nicotine effects on the physostigmine-induced tremor are discussed. |
PubMedSearch : da Fonseca Ade_2005_Pharmacol.Biochem.Behav_81_551 |
PubMedID: 15964616 |
da Fonseca Ade S, Santos R (2005)
Nicotine pretreatment diminished physostigmine-induced tremor in rats
Pharmacol Biochem Behav
81 :551
da Fonseca Ade S, Santos R (2005)
Pharmacol Biochem Behav
81 :551